Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop

Nature Structural Biology

Volumn 3, Issue 10, 1996, Pages 881-887

  Schumacher, Maria A ^a   Carter, Darrick ^a   Roos, David S ^b   Ullman, Buddy ^a   Brennan, Richard G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

CATALYSIS; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME MECHANISM; NONHUMAN; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TOXOPLASMA GONDII;

ANIMALS; BINDING SITES; PENTOSYLTRANSFERASES; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY; TOXOPLASMA;

TOXOPLASMA GONDII;

EID: 0029742013     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb1096-881     Document Type: Review

References (38)

1. Frenkel, J.K. in The Coccidia (ed. D.M. Hammond) 343-410 (Baltimore University Press, 1973).
2. McAuley, J. et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clinical Infectious Diseases 19, 33-72 (1994).
3. Daffos, F. et al. Toxoplasma in pregnancy. Lancet 344, 54-61 (1994).
4. Luft, B.J. & Remington, J.S. Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases 15, 211-222 (1992).
5. Mariuz, P., Bosler, E.M. & Luft, B.J. Toxoplasmosis in individuals with AIDS. Infectious Disease Clinics of North America 8, 365-381 (1994).
6. Leport, C. et al. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the Acquired Immunodeficiency Syndrome. Amer. J. Med. 84, 94-100 (1987).
7. Fernandez-Martin, J. et al. Pyrimethamine-clarithromycin combination for therapy of acute toxoplasma encephalitis in patients with AIDS. Antimicrobial Agents and Chemotherapy 35, 2049-2052 (1991).
8. Tenant-Flowers, M. Sulfadiazine desensitization in patients with AIDS and cerebral toxoplasmosis. AIDS 5, 311-315 (1991).
9. Laughon, B.E. et al. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS. J Infect Dis. 164, 244-251 (1991).
10. Dannemann, B. et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine and sulfadiazine. Annals of Internal Medicine 116, 33-43 (1992).
11. Ullman, B. & Allen, T.E. Hypoxanthine-guanine phosphoribosyltransferase in trypanosomatids: a rational target for antiparasitic chemotherapy. Molecular Approaches to Parasitology. (Ed. John Boothroyd) 123-141 (Wiley-Liss Division, 1995).
12. Musick, D.L. Structural features of the phosphoribosyltransferases and their relationship to the human deficiency disorders of purine and pyrimidine metabolism. CRC Crit. Rev. Biochem. 11, 1-33 (1981).
13. Argos, P. Hanei, M., Wilson, J.M. & Kelley, W.N. A possible nucleotide-binding domain in the tertiary fold of phosphoribosyltransferases. J. Biol. Chem. 258, 6450-6457 (1983).
14. Smith, J.L. Enzymes of nucleotide synthesis. Curr. Opin. Struct. Biol. 5, 752-757 (1995).
15. Donald, R.G.K., Carter, D., Ullman, B. & Roos, D.S. Insertional tagging, cloning and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene: characterization of a new genetic marker for stable transformation. J. Biol. Chem. 271, 14010-14019 (1996).
16. Giacomello, A. & Salerno, C. Human hypoxanthine-guanine phosphoribosyltransferase. J. Biol. Chem. 253, 6038-6044 (1978)..
17. Yuan, L., Craig III, S.P., McKerrow & J.H. & Wang, C.C. Steady-state kinetics of the schistosomal hypoxanthine-guanine phosphoribosyl-transferase. Biochemistry 31, 806-810 (1992).
18. 3H substrate kinetic isotope effects for some phosphoribosyl-transferases. J. Biol. Chem. 253, 2963-2971 (1978).
19. Tao, W., Grubmeyer, C. & Blanchard, J.S. Transition state structure of Salmonella typhimurium orotate phosphoribosyltransferase. Biochemistry 35, 14-21 (1996).
20. Eads, J.C., Scapin, G., Xu, Y., Grubmeyer, C. & Sacchettini, J.C. The crystal structure of human hypoxanthine-guanine phosphoribosyl-transferase with bound GMP. Cell 78, 325-334 (1994).
21. Somoza, J.R., Chin, M.S., Focia, P.J., Wang, C.C. & Fletterick, R.J. Crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from the protozoan parasite Tritrichomonas foetus. Biochemistry 35, 7032-7040 (1996).
22. Tronrud, D.E., Ten Eydc, L.F. & Matthews, B.W. An efficient general purpose least-squares refinement program for macromolecular structures. Acta crystallogr. A43, 489-501 (1985).
23. Laskowski, R.A., MacArthur, M.W. & Thorton, J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291 (1993).
24. Johnson, G.G., Eisenberg, L.R. & Migeon, B.R. Human and mouse hypoxanthine-guanine phosphoribosyltransferase: dimers and tetramers. Science 203, 174-176 (1979).
25. Ullman, B. & Carter, D. Hypoxanthine-guanine phosphoribosyl-transferase as a therapeutic target in protozoal infections. Infectious Agents and Disease 4, 29-40 (1995).
26. Wilson, J.M. et al. A molecular survey of hypoxanthine-guanine phosphoribosyltransferase deficiency in man. J. Clin. Invest. 77, 188-195 (1986).
27. Henriksen, A., Aghajari, N., Jensen, K.F. & Gajhede, M. A flexible loop at the dimer interface is a part of the active site of the adjacent monomer of Escherichia coli orotate phosphoribosyltransferase. Biochemistry 35, 3803-3809 (1996).
28. Parry, R.J. & Haridas, K. Synthesis of 1-α-pyrophosphoryl-2α,3α-dihydroxy-4-β- cyclopentanemethanol-5-phosphate. Tetrahedron Lett. 34, 7013-7016 (1993).
29. Kim, J.H. et al. (1995). A stable carbocydic analog of 5-phosphoribosyl-1-pyrophosphate to probe the mechanism of catalysis and regulation of glutamine phosphoribosylpyrophosphate amidotransferase. J. Biol. Chem. 270, 17394-17399 (1995).
30. Smith, J.L. et al. Structure of the allosteric regulatory enzyme of purine biosynthesis. Science 264, 1427-1433 (1994).
31. Scapin, G., Ozturk, D.H., Grubmeyer, C. & Sacchettini, J.C. The crystal structure of the orotate phosphoribosyltransferase complexed with orotate and α-D-phosphoribosyl-1-pyrophosphate. Biochemistry 34, 10744-10754 (1995).
32. Cohen, F.C., Blaney, J.M., Humblet, C., Gund, P. & Barry, D.C. Molecular software and methods for medicinal chemistry. J. Med. Chem. 33, 883-894 (1995).
33. Roos, D.S., Donald, R.G.K., Morrissette, N.S. & Moulton, A.L.C. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Meths. Cell Biol. 45, 27-63 (1994).
34. Xuong, N.H., Nielsen, C., Hamlin, R. & Anderson, D.J. Strategy for data collection from protein crystals using a multiwire counter area detector diffractometer. J. Appl. Crystallogr. 18, 342-350 (1985).
35. 15N heteronuclear NMR studies of Escherichia coli thioredoxin in samples isotopically labeled by residue type. Biochemistry 24, 7263-7268 (1985).
36. Terwilliger, T.C. & Eisenberg, D. Unbiased three-dimensional refinement of heavy atom parameters by correlation of origin-removed patterson functions. Acta Crystallogr. A39, 813-817 (1983).
37. Jones, T.A. Interactive computer program graphics: FRODO. Meths. Enzymol. B115, 157-171 (1985).
38. Kraulis, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cyst. 24, 946-950 (1991).